EA201490892A1 - Усовершенствованный способ получения промежуточного соединения макроциклического ингибитора tmc 435 протеазы - Google Patents
Усовершенствованный способ получения промежуточного соединения макроциклического ингибитора tmc 435 протеазыInfo
- Publication number
- EA201490892A1 EA201490892A1 EA201490892A EA201490892A EA201490892A1 EA 201490892 A1 EA201490892 A1 EA 201490892A1 EA 201490892 A EA201490892 A EA 201490892A EA 201490892 A EA201490892 A EA 201490892A EA 201490892 A1 EA201490892 A1 EA 201490892A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- proteas
- obtaining
- tmc
- improved method
- intermediate compound
- Prior art date
Links
- JTZZSQYMACOLNN-VDWJNHBNSA-N simeprevir Chemical compound O=C([C@@]12C[C@H]1\C=C/CCCCN(C)C(=O)[C@H]1[C@H](C(N2)=O)C[C@H](C1)OC=1C2=CC=C(C(=C2N=C(C=1)C=1SC=C(N=1)C(C)C)C)OC)NS(=O)(=O)C1CC1 JTZZSQYMACOLNN-VDWJNHBNSA-N 0.000 title abstract 3
- 229960002091 simeprevir Drugs 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 241000208465 Proteaceae Species 0.000 title 1
- 235000019419 proteases Nutrition 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 150000002678 macrocyclic compounds Chemical class 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11187025 | 2011-10-28 | ||
| PCT/IB2012/055900 WO2013061285A1 (en) | 2011-10-28 | 2012-10-26 | Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201490892A1 true EA201490892A1 (ru) | 2014-08-29 |
Family
ID=47221505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201490892A EA201490892A1 (ru) | 2011-10-28 | 2012-10-26 | Усовершенствованный способ получения промежуточного соединения макроциклического ингибитора tmc 435 протеазы |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8981082B2 (enExample) |
| EP (1) | EP2771339B1 (enExample) |
| JP (1) | JP6231482B2 (enExample) |
| KR (1) | KR20140086967A (enExample) |
| CN (1) | CN104053658B (enExample) |
| AR (1) | AR088568A1 (enExample) |
| AU (1) | AU2012327934B2 (enExample) |
| BR (1) | BR112014009849A2 (enExample) |
| CA (1) | CA2848377A1 (enExample) |
| CL (1) | CL2014001043A1 (enExample) |
| EA (1) | EA201490892A1 (enExample) |
| ES (1) | ES2671732T3 (enExample) |
| HK (1) | HK1202120A1 (enExample) |
| IL (1) | IL231892A (enExample) |
| MX (1) | MX347650B (enExample) |
| TW (1) | TWI574960B (enExample) |
| WO (1) | WO2013061285A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41812A (fr) | 2015-03-27 | 2018-01-30 | Janssen Pharmaceuticals Inc | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
| WO2017064680A1 (en) * | 2015-10-16 | 2017-04-20 | Lupin Limited | An improved process for the preparation of simeprevir sodium and intermediate thereof |
| CN109846883A (zh) * | 2017-11-30 | 2019-06-07 | 常州寅盛药业有限公司 | 苯并呋喃衍生物与tmc435联合用药物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1771257A (zh) * | 2003-04-10 | 2006-05-10 | 贝林格尔·英格海姆国际有限公司 | 通过钌络合物催化的易位反应制备大环化合物的方法 |
| PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| ATE510846T1 (de) * | 2005-09-09 | 2011-06-15 | Boehringer Ingelheim Int | Cyclisierendes metatheseverfahren zur herstellung von makrocyclischen peptiden |
| US8193346B2 (en) | 2007-12-06 | 2012-06-05 | Enanta Pharmaceuticals, Inc. | Process for making macrocyclic oximyl hepatitis C protease inhibitors |
| AU2009278075B2 (en) * | 2008-08-07 | 2013-07-04 | F. Hoffmann-La Roche Ag | Process for the preparation of a macrocycle |
| BRPI0923393B1 (pt) | 2008-12-23 | 2018-06-19 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | "processos para preparar um inibidor de protease de hcv macrocíclico e intermediários e uso". |
-
2012
- 2012-10-26 MX MX2014005070A patent/MX347650B/es active IP Right Grant
- 2012-10-26 JP JP2014537794A patent/JP6231482B2/ja not_active Expired - Fee Related
- 2012-10-26 CN CN201280052692.3A patent/CN104053658B/zh not_active Expired - Fee Related
- 2012-10-26 BR BR112014009849A patent/BR112014009849A2/pt not_active IP Right Cessation
- 2012-10-26 US US14/350,138 patent/US8981082B2/en not_active Expired - Fee Related
- 2012-10-26 KR KR1020147009887A patent/KR20140086967A/ko not_active Ceased
- 2012-10-26 AR ARP120104040A patent/AR088568A1/es unknown
- 2012-10-26 EA EA201490892A patent/EA201490892A1/ru unknown
- 2012-10-26 EP EP12790677.4A patent/EP2771339B1/en active Active
- 2012-10-26 WO PCT/IB2012/055900 patent/WO2013061285A1/en not_active Ceased
- 2012-10-26 HK HK15102687.7A patent/HK1202120A1/xx unknown
- 2012-10-26 CA CA2848377A patent/CA2848377A1/en not_active Abandoned
- 2012-10-26 AU AU2012327934A patent/AU2012327934B2/en not_active Ceased
- 2012-10-26 ES ES12790677.4T patent/ES2671732T3/es active Active
- 2012-10-26 TW TW101139616A patent/TWI574960B/zh not_active IP Right Cessation
-
2014
- 2014-04-03 IL IL231892A patent/IL231892A/en not_active IP Right Cessation
- 2014-04-24 CL CL2014001043A patent/CL2014001043A1/es unknown
-
2015
- 2015-02-09 US US14/616,770 patent/US9328108B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20150152098A1 (en) | 2015-06-04 |
| KR20140086967A (ko) | 2014-07-08 |
| HK1202120A1 (en) | 2015-09-18 |
| BR112014009849A2 (pt) | 2016-07-05 |
| AU2012327934A1 (en) | 2014-03-20 |
| AU2012327934B2 (en) | 2017-06-01 |
| US9328108B2 (en) | 2016-05-03 |
| US20140235852A1 (en) | 2014-08-21 |
| IL231892A (en) | 2017-09-28 |
| TW201323423A (zh) | 2013-06-16 |
| TWI574960B (zh) | 2017-03-21 |
| ES2671732T3 (es) | 2018-06-08 |
| EP2771339B1 (en) | 2018-04-18 |
| CN104053658A (zh) | 2014-09-17 |
| IL231892A0 (en) | 2014-05-28 |
| CN104053658B (zh) | 2018-03-13 |
| MX347650B (es) | 2017-05-05 |
| CL2014001043A1 (es) | 2014-07-25 |
| JP6231482B2 (ja) | 2017-11-15 |
| AR088568A1 (es) | 2014-06-18 |
| EP2771339A1 (en) | 2014-09-03 |
| JP2014530901A (ja) | 2014-11-20 |
| WO2013061285A1 (en) | 2013-05-02 |
| MX2014005070A (es) | 2014-08-22 |
| CA2848377A1 (en) | 2013-05-02 |
| US8981082B2 (en) | 2015-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007013242D1 (de) | Herstellung von essigsäure | |
| EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
| NO20076371L (no) | Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner | |
| IN2014MN01521A (enExample) | ||
| EA201101587A1 (ru) | 4-циано-3-бензоиламино-n-фенилбензамиды для использования в борьбе с вредителями | |
| CR20180517A (es) | INHIBIDORES DE LAS PROTEASAS DE SERINA DEL VHC DERIVADOS DE PROLINAS MACROCICLICAS (Divisional 2013-0135) | |
| EA201301320A1 (ru) | 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу | |
| UA117800C2 (uk) | Похідні урацилу або тиміну для лікування гепатиту с | |
| MX340572B (es) | Proceso para la fabricacion de compuestos farmaceuticamente activos. | |
| EA201390156A1 (ru) | ПРОИЗВОДСТВО ИНТЕР-АЛЬФА-ИНГИБИТОРНЫХ БЕЛКОВ (IaIp) ИЗ ПЛАЗМЫ | |
| EA201390433A1 (ru) | Ингибиторы вируса гепатита с | |
| BR112013010372A2 (pt) | composto, e, método para preparar um composto | |
| HRP20080554B1 (hr) | Postupak priprave inhibitora proteaze hiv | |
| EA201101588A1 (ru) | Инсектицидные соединения | |
| ATE517869T1 (de) | Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon | |
| EA201391554A1 (ru) | Способы получения макроциклических депсипептидов и новых промежуточных соединений | |
| EA201201174A1 (ru) | Новый способ получения дронедарона | |
| EA201490892A1 (ru) | Усовершенствованный способ получения промежуточного соединения макроциклического ингибитора tmc 435 протеазы | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| EA201400475A1 (ru) | Способы получения новых производных бензимидазола | |
| EA201270237A1 (ru) | Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний | |
| EA201391721A1 (ru) | Способ получения полиморфной формы i эторикоксиба | |
| WO2009116081A3 (en) | An improved process for the preparation of aprepitant | |
| NO20076161L (no) | Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner | |
| MX2013012771A (es) | Proceso para la preparacion de inhibidores del virus de la hepatitis c. |